ADVAC is co-sponsored by:
- Africa Centres for Disease Control and Prevention
- Bill & Melinda Gates Foundation
- Centers for Disease Control and Prevention (CDC)
- Coalition for Epidemic Preparedness Innovations (CEPI)
- European Centre for Disease Prevention and Control (ECDC)
- European & Developing Countries Clinical Trials Partnership (EDCTP)
- European Society for Paediatric Infectious Diseases (ESPID)
- Fogarty International Center at the National Institutes of Health
- International Pediatric Association (IPA)
- Johns Hopkins Bloomberg School of Public Health
- National Institutes of Health (NIH/NIAID-USA)
Funding
ADVAC is funded by the participants’ registration fees, education grants, a grant from the Bill & Melinda Gates Foundation and in-kind contributions from the organizing and co-sponsoring agencies.
Sponsors providing unrestricted education grants and sponsor grants:
Bio Manguinhos • Coalition for Epidemic Preparedness Innovations • GlaxoSmithKline • Jonhson & Johnson • Merck • Moderna • Pfizer • Sanofi • Serum Institute of India • Takeda
Fellowships
For selected ADVAC participants, fellowships are supported by grants funding from the Bill & Melinda Gates Foundation, the European & Developing Countries Clinical Trials Partnership (EDCTP) and the European Society for Paediatric Infectious Diseases (ESPID).
The Bill & Melinda Gates Foundation will provide fellowships for selected candidates from Low- and Middle-Income Countries.
The European & Developing Countries Clinical Trials Partnership (EDCTP) will provide fellowships for selected candidates from Sub-Saharan African countries.
The Fogarty International Center at the US National Institutes of Health will provide fellowships for selected candidates from Low- and Middle-Income Countries.
The European Society for Paediatric Infectious Diseases (ESPID) will provide fellowships for selected ESPID members of good standing whose ESPID membership fees have been paid up in full. For further details, please consult the ESPID website.